Business Context and Reporting Period
This Form 8-K filing by Bristol-Myers Squibb Co reports the results of the Annual Meeting of Shareholders held on May 29, 2019. The document details the voting outcomes for director elections, executive compensation, auditor ratification, and a shareholder proposal.
Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
As this report covers a discrete event (the annual meeting) rather than a financial period, there are no material changes in financial performance to report versus a prior comparable period.
Outlook, Risks, and Voting Results
The filing outlines the following key voting outcomes:
- Director Elections: All 11 nominees were elected to serve until the 2020 Annual Meeting. Vote counts varied by nominee, with "For" votes ranging from approximately 1.09 billion to 1.18 billion.
- Executive Compensation: The advisory vote to approve the compensation of named executive officers was approved with 1,104,120,140 votes "For" and 83,372,093 votes "Against".
- Auditor Ratification: The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2019 was ratified with 1,399,501,334 votes "For".
- Shareholder Proposal: A shareholder proposal regarding the right to act by written consent was not approved. It received 521,251,648 votes "For" and 662,700,015 votes "Against".
Key Facts for Investors
- Management successfully retained control of the board with all 11 nominees elected.
- Shareholders approved the "Say on Pay" proposal, though a significant minority (approx. 7%) voted against it.
- The shareholder proposal to allow action by written consent was defeated by a margin of over 140 million votes.
- Deloitte & Touche LLP remains the company's independent auditor for the 2019 fiscal year.
- This filing contains no financial performance data; investors should refer to the 10-K or 10-Q for financial metrics.